Enzalutamide/enzalutamide latest price in 2024

Enzalutamide/enzalutamide is indicated for the treatment of castration-resistant prostate cancer, metastatic castration-sensitive prostate cancer (mCSPC) and non-metastatic castration-sensitive prostate cancer (NMC SPC) with a high risk of metastasis (high-risk BCR). It is also indicated in combination with talazoparib for the treatment of adult patients with mCRPC with HRR gene mutations.

Enzalutamide was generally well tolerated, with the most common adverse events (AEs; occurring in ≥5% of patients) being fatigue, hot flushes, diarrhea, hypertension, and musculoskeletal pain. Use of the drug should be initiated and monitored by a doctor experienced in treating prostate cancer. Enzalutamide is available as capsules (40 mg) and tablets (40 and 80 mg) and is available by prescription only. The usual dose is 160 mg once daily, taken around the same time each day. If a patient experiences certain side effects, the doctor may have to reduce the dose or interrupt treatment.

In the domestic market, the original drug of enzalutamide has appeared in the form of soft capsules and enjoys the reimbursement policy of Class B medical insurance. The common drug specifications are 40mg*112 capsules/box, and the price is about 6,000 yuan. In overseas markets such as Türkiye, the price of each box of original drugs of the same specifications may exceed 10,000 yuan, and the specific price is affected by exchange rate fluctuations. It is worth mentioning that there are also generic drugs available overseas, and the ingredients of these drugs are similar to the original drugs. For example, the price of generic drugs of the same specification produced by pharmaceutical factories in Laos and India is about more than 2,000 yuan per box, but the price will also fluctuate due to exchange rate changes.